-
- Stock symbol: DNA (NYSE)
- Annual revenue (2007): $2.9 billion
- Founders: Robert A. Swanson, Herbert W. Boyer
- Year established: 1976
- Industry: Biotechnology
- Phone: 650-225-1000
- Fax: 650-225-6000+
- Headquarters: South San Francisco, California
- CEO: Dr. Arthur D. Levinson
- CFO: David A. Ebersman
- Staff (as of 2007): 10,560
-
Genentech on Amazon
-
-
60 Minutes - The Captain of Capitalism (November 4, 2007) - $17.95
Airdate: 11/04/07 If there were a hall of fame for business tycoons, Tom Perkins would be a first-ballot shoo-in. He is a Silicon Valley original, a venture capitalist behind some...Amazon
-
Long-term efalizumab helps maintain gains of psoriasis therapy. (Good Compliance).(Xanelim tested by Genentech Inc.): An article from: Skin & Allergy News - $5.95
This digital document is an article from Skin & Allergy News, published by International Medical News Group on March 1, 2002. The length of the article is 411 words. The page lengt...Amazon
-
Genentech, Incyte Genomics tell House Subcommittee gene patents essential for medical progress.(Brief Article): An article from: BIOTECH Patent News - $5.95
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on July 1, 2000. The length of the article is 2368 words. The page length shown above...Amazon
view more products...
-
-
-
Genentech Questions
-
What is the best market niche for my writing and consulting business in st. louis? 1 AnswerI've watched this go unanswered for too long. ;-) While I'm not in St. Louis, I have parlayed my writing into a consultancy business recently and I can offer a ... read more
view more questions...
-
-
-
Genentech on Amazon
-
60 Minutes - The Captain of Capitalism (November 4, 2007) - $17.95
Airdate: 11/04/07 If there were a hall of fame for business tycoons, Tom Perkins would be a first-ballot shoo-in. He is a Silicon Valley original, a venture capitalist behind some...Amazon
-
Long-term efalizumab helps maintain gains of psoriasis therapy. (Good Compliance).(Xanelim tested by Genentech Inc.): An article from: Skin & Allergy News - $5.95
This digital document is an article from Skin & Allergy News, published by International Medical News Group on March 1, 2002. The length of the article is 411 words. The page lengt...Amazon
-
Genentech Professional Background Report - $0.99
The Genentech Professional Background Report is a high quality publication created using ChoiceLevel.com, which is a background check report website that allows people and business...Amazon
-
GENENTECH REPORTS POSITIVE PHASE II RESULTS FOR ANTI-VEGF.(recombinant humanized monoclonal antibody to vascular endothelial cell growth factor)(Statistical ... Included): An article from: Biotech Business - $5.95
This digital document is an article from Biotech Business, published by Worldwide Videotex on July 1, 2000. The length of the article is 1223 words. The page length shown above is ...Amazon
view more products...
-
-
-
Genentech on Amazon
-
60 Minutes - The Captain of Capitalism (November 4, 2007) - $17.95
Airdate: 11/04/07 If there were a hall of fame for business tycoons, Tom Perkins would be a first-ballot shoo-in. He is a Silicon Valley original, a venture capitalist behind some...Amazon
-
Long-term efalizumab helps maintain gains of psoriasis therapy. (Good Compliance).(Xanelim tested by Genentech Inc.): An article from: Skin & Allergy News - $5.95
This digital document is an article from Skin & Allergy News, published by International Medical News Group on March 1, 2002. The length of the article is 411 words. The page lengt...Amazon
-
Genentech, Incyte Genomics tell House Subcommittee gene patents essential for medical progress.(Brief Article): An article from: BIOTECH Patent News - $5.95
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on July 1, 2000. The length of the article is 2368 words. The page length shown above...Amazon
-
view more products...
-
-
On Twitter Powered by Twitter
-
San Francisco: FDA panel snubs Genentech lung cancer drug http://bit.ly/6mD7IB
-
Scott Revelli Wins Genentech PR&D 2009 Outstanding Junior Award. Congratulations Scott!!!
-
Returning to present results on micro-learning and micro-gaming for Genentech at Training Mag's Leadership Summit in May 2010
-
FDA ODAC meeting today to discuss OSI/Roche/Genentech's Tarceva for maintenance therapy in lung cancer! http://bit.ly/4RcgyA
-
RT @healtylife: Genentech wants lung cancer drug expanded - San Francisco Business Times http://twa.lk/Mml46
view more tweets...
-
-
On Twitter Powered by Twitter
-
San Francisco: FDA panel snubs Genentech lung cancer drug http://bit.ly/6mD7IB
-
Scott Revelli Wins Genentech PR&D 2009 Outstanding Junior Award. Congratulations Scott!!!
-
Returning to present results on micro-learning and micro-gaming for Genentech at Training Mag's Leadership Summit in May 2010
-
FDA ODAC meeting today to discuss OSI/Roche/Genentech's Tarceva for maintenance therapy in lung cancer! http://bit.ly/4RcgyA
-
RT @healtylife: Genentech wants lung cancer drug expanded - San Francisco Business Times http://twa.lk/Mml46
view more tweets...
-
-
On Twitter Powered by Twitter
-
San Francisco: FDA panel snubs Genentech lung cancer drug http://bit.ly/6mD7IB
-
Scott Revelli Wins Genentech PR&D 2009 Outstanding Junior Award. Congratulations Scott!!!
-
Returning to present results on micro-learning and micro-gaming for Genentech at Training Mag's Leadership Summit in May 2010
-
FDA ODAC meeting today to discuss OSI/Roche/Genentech's Tarceva for maintenance therapy in lung cancer! http://bit.ly/4RcgyA
-
RT @healtylife: Genentech wants lung cancer drug expanded - San Francisco Business Times http://twa.lk/Mml46
view more tweets...
-
About this page
-
Page Views0
No one is currently managing this page.
If you would like to apply
to be the manager of this page, please request below.
If you would like to apply
to be the manager of this page, please request below.
This page currently has no vertical manager.
